Center-Authored Papers

Filters: Author is Hingorani, Sunil R  [Clear All Filters]
2008
Flaherty KT, Schiller J, Schuchter LM, Liu G, Tuveson DA, Redlinger M, Lathia C, Xia C, Petrenciuc O, Hingorani SR et al..  2008.  A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(15):4836-42. Abstract
2009
Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D et al..  2009.  Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.. Science (New York, N.Y.). 324(5933):1457-61. Abstract
Philip PA, Mooney M, Jaffe D, Eckhardt G, Moore M, Meropol N, Emens L, O'Reilly E, Korc M, Ellis L et al..  2009.  Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(33):5660-9. Abstract
2010
Goicoechea SM, Bednarski B, Stack C, Cowan DW, Volmar K, Thorne L, Cukierman E, Rustgi AK, Brentnall T, Hwang RF et al..  2010.  Isoform-specific upregulation of palladin in human and murine pancreas tumors.. PloS one. 5(4):e10347. Abstract
2012
Solan JL, Hingorani SR, Lampe PD.  2012.  Changes in connexin43 expression and localization during pancreatic cancer progression.. The Journal of membrane biology. 245(5-6):255-62. Abstract
Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR.  2012.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.. Cancer cell. 21(3):418-29. Abstract
Hingorani SR, Potter JD.  2012.  Pancreas cancer meets the thunder god.. Science translational medicine. 4(156):156ps21. Abstract
2013
Provenzano PP, Hingorani SR.  2013.  Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer.. British journal of cancer. 108(1):1-8. Abstract
Husain K, Centeno BA, Chen D-T, Fulp WJ, Perez M, Zhang Lee G, Luetteke N, Hingorani SR, Sebti SM, Malafa MP.  2013.  Prolonged survival and delayed progression of pancreatic intraepithelial neoplasia in LSL-KrasG12D/+;Pdx-1-Cre mice by vitamin E δ-tocotrienol.. Carcinogenesis. Abstract
Spivak-Kroizman TR, Hostetter G, Posner R, Aziz M, Hu C, Demeure MJ, Von Hoff D, Hingorani SR, Palculict TB, Izzo J et al..  2013.  Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer.. Cancer research. 73(11):3235-47. Abstract
Husain K, Centeno BA, Chen D-T, Hingorani SR, Sebti SM, Malafa MP.  2013.  Vitamin E δ-Tocotrienol Prolongs Survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) Transgenic Mouse Model of Pancreatic Cancer.. Cancer prevention research (Philadelphia, Pa.). 6(10):1074-83. Abstract
2014
Mirus JE, Zhang Y, Hollingsworth MA, Solan JL, Lampe PD, Hingorani SR.  2014.  Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.. Molecular & cellular proteomics : MCP. 13(12):3484-96. Abstract
Stromnes IM, Schmitt TM, Chapuis AG, Hingorani SR, Greenberg PD.  2014.  Re-adapting T cells for cancer therapy: from mouse models to clinical trials.. Immunological reviews. 257(1):145-64. Abstract
Hingorani SR.  2014.  Cellular and molecular conspirators in pancreas cancer.. Carcinogenesis. 35(7):1435.
Stromnes IM, DelGiorno KE, Greenberg PD, Hingorani SR.  2014.  Stromal re-engineering to treat pancreas cancer.. Carcinogenesis. 35(7):1451-60. Abstract
DelGiorno KE, Carlson MA, Osgood R, Provenzano PP, Brockenbough SJ, Thompson CB, Shepard MH, Frost GI, Potter JD, Hingorani SR.  2014.  Response to chauhan et Al.: interstitial pressure and vascular collapse in pancreas cancer-fluids and solids, measurement and meaning.. Cancer cell. 26(1):16-7.
Stromnes IM, Brockenbrough SJ, Izeradjene K, Carlson MA, Cuevas C, Simmons RM, Greenberg PD, Hingorani SR.  2014.  Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity.. Gut. 63(11):1769-81. Abstract
Stromnes IM, Greenberg PD, Hingorani SR.  2014.  Molecular Pathways: Myeloid Complicity in Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(20):5157-70. Abstract
2015
Whittle MC, Hingorani SR.  2015.  Disconnect between EMT and metastasis in pancreas cancer.. Oncotarget. 6(31):30445-30446.
Mirus JE, Zhang Y, Li CI, Lokshin AE, Prentice RL, Hingorani SR, Lampe PD.  2015.  Cross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. 21(7):1764-71. Abstract
Hingorani SR.  2015.  Intercepting Cancer Communiques: Exosomes as Heralds of Malignancy.. Cancer cell. 28(2):151-3. Abstract
Tabernero J, Chiorean GE, Infante JR, Hingorani SR, Ganju V, Weekes C, Scheithauer W, Ramanathan RK, Goldstein D, Penenberg DN et al..  2015.  Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer.. The oncologist. 20(2):143-50. Abstract
Whittle MC, Izeradjene K, Rani GP, Feng L, Carlson MA, DelGiorno KE, Wood LD, Goggins M, Hruban RH, Chang AE et al..  2015.  RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma.. Cell. 161(6):1345-60. Abstract
Stromnes IM, Schmitt TM, Hulbert A, Brockenbrough SJ, Nguyen HN, Cuevas C, Dotson AM, Tan X, Hotes JL, Greenberg PD et al..  2015.  T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma.. Cancer cell. 28(5):638-52. Abstract
2016
Kuo C-T, Thompson AM, Gallina ME, Ye F, Johnson ES, Sun W, Zhao M, Yu J, Wu I-C, Fujimoto B et al..  2016.  Optical painting and fluorescence activated sorting of single adherent cells labelled with photoswitchable Pdots.. Nature communications. 7:11468. Abstract